Clinical trial
Gluten Free Diet for AML Patients Undergoing Induction Chemotherapy
NCT03108911 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gluten Free Diet for AML Patients Undergoing Induction Chemotherapy
- Lead sponsor
- Rutgers, The State University of New Jersey
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 27, 2017
- Completion date
- November 14, 2017
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute myeloid leukemia